CN107595857A - 用于眼部疾病和病症的组合物和治疗 - Google Patents

用于眼部疾病和病症的组合物和治疗 Download PDF

Info

Publication number
CN107595857A
CN107595857A CN201710063950.2A CN201710063950A CN107595857A CN 107595857 A CN107595857 A CN 107595857A CN 201710063950 A CN201710063950 A CN 201710063950A CN 107595857 A CN107595857 A CN 107595857A
Authority
CN
China
Prior art keywords
progesterone
use according
patient
composition
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710063950.2A
Other languages
English (en)
Chinese (zh)
Inventor
张葳葳
肯尼斯·索耶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glia LLC
Original Assignee
Glia LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glia LLC filed Critical Glia LLC
Publication of CN107595857A publication Critical patent/CN107595857A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
CN201710063950.2A 2012-07-27 2013-07-26 用于眼部疾病和病症的组合物和治疗 Pending CN107595857A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261676530P 2012-07-27 2012-07-27
US61/676,530 2012-07-27
US201361756321P 2013-01-24 2013-01-24
US61/756,321 2013-01-24
CN201380039713.2A CN104661663A (zh) 2012-07-27 2013-07-26 用于眼部疾病和病症的组合物和治疗

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201380039713.2A Division CN104661663A (zh) 2012-07-27 2013-07-26 用于眼部疾病和病症的组合物和治疗

Publications (1)

Publication Number Publication Date
CN107595857A true CN107595857A (zh) 2018-01-19

Family

ID=49997851

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201710063950.2A Pending CN107595857A (zh) 2012-07-27 2013-07-26 用于眼部疾病和病症的组合物和治疗
CN201380039713.2A Pending CN104661663A (zh) 2012-07-27 2013-07-26 用于眼部疾病和病症的组合物和治疗

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201380039713.2A Pending CN104661663A (zh) 2012-07-27 2013-07-26 用于眼部疾病和病症的组合物和治疗

Country Status (20)

Country Link
US (2) US20150216877A1 (https=)
EP (1) EP2877184B1 (https=)
JP (1) JP6209777B2 (https=)
KR (1) KR102097663B1 (https=)
CN (2) CN107595857A (https=)
AU (1) AU2013295645B2 (https=)
BR (1) BR112015001847A8 (https=)
CA (1) CA2880027C (https=)
DK (1) DK2877184T3 (https=)
ES (1) ES2759781T3 (https=)
HU (1) HUE046963T2 (https=)
IL (1) IL236920B (https=)
IN (1) IN2015DN00542A (https=)
MX (1) MX362185B (https=)
NZ (1) NZ704247A (https=)
PL (1) PL2877184T3 (https=)
PT (1) PT2877184T (https=)
SM (1) SMT201900678T1 (https=)
WO (1) WO2014018856A1 (https=)
ZA (1) ZA201500561B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
ES2649730T3 (es) 2013-03-15 2018-01-15 Glia Llc Distribución craneal de compuestos farmacéuticos
WO2015080758A1 (en) * 2013-11-27 2015-06-04 Al-Qahtani Ahmed H Method and composition for the treatment of moderate to severe keratoconjunctivitis sicca
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
EP3171872B1 (en) 2014-07-21 2020-11-11 Glia, LLC Method for treating radiotherapy-and-chemotherapy associated cognitive or emotional impairment with cannabinoids
RU2016141135A (ru) 2014-07-29 2018-08-28 Терапьютиксмд, Инк. Трансдермальный крем
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
KR101960023B1 (ko) * 2016-12-21 2019-03-20 김보경 이산화탄소 발생 장치
WO2021163253A1 (en) * 2020-02-12 2021-08-19 Glia, Llc Progesterone combinations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100016264A1 (en) * 2007-12-05 2010-01-21 Connor Charles G Treatment for dry eye using testosterone and progestagen
CN101757622A (zh) * 2008-11-28 2010-06-30 天津金耀集团有限公司 一种眼部抗炎的药物组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102656A (en) 1983-07-29 1992-04-07 The Mennen Company Antiperspirant creams
US4937069A (en) 1985-11-15 1990-06-26 Bristol-Myers Squibb Company Anhydrous semi-solid antiperspirant suspension
US5069897A (en) 1987-10-16 1991-12-03 The Proctor & Gamble Company Antiperspirant creams
US6659985B2 (en) 2002-01-30 2003-12-09 Southern College Of Optometry Method to use transdermal administration of androgens to the adnexa of the eye
US7572780B2 (en) * 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
US20080132475A1 (en) * 2006-12-05 2008-06-05 Charles Gerald Connor Treatment for dry eye
NZ584275A (en) * 2007-10-08 2012-06-29 Fovea Pharmaceuticals Aqueous cyclosporine ophthalmic formulations
US10029013B2 (en) * 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100016264A1 (en) * 2007-12-05 2010-01-21 Connor Charles G Treatment for dry eye using testosterone and progestagen
CN101757622A (zh) * 2008-11-28 2010-06-30 天津金耀集团有限公司 一种眼部抗炎的药物组合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
杨文等主编: "《老年医学分册 下》", 31 December 2010, 吉林大学出版社 *

Also Published As

Publication number Publication date
PL2877184T3 (pl) 2020-04-30
IL236920B (en) 2018-06-28
HUE046963T2 (hu) 2020-04-28
HK1210968A1 (en) 2016-05-13
PT2877184T (pt) 2019-12-02
ZA201500561B (en) 2016-04-28
JP6209777B2 (ja) 2017-10-11
EP2877184A1 (en) 2015-06-03
ES2759781T3 (es) 2020-05-12
EP2877184A4 (en) 2016-03-30
DK2877184T3 (da) 2019-12-09
NZ704247A (en) 2018-04-27
CN104661663A (zh) 2015-05-27
AU2013295645B2 (en) 2017-08-24
MX2015001250A (es) 2015-10-22
KR20150038311A (ko) 2015-04-08
AU2013295645A1 (en) 2015-02-05
US20170189413A1 (en) 2017-07-06
WO2014018856A1 (en) 2014-01-30
SMT201900678T1 (it) 2020-03-13
US9925201B2 (en) 2018-03-27
BR112015001847A8 (pt) 2021-09-08
MX362185B (es) 2019-01-08
JP2015524434A (ja) 2015-08-24
IN2015DN00542A (https=) 2015-06-26
BR112015001847A2 (pt) 2017-07-04
KR102097663B1 (ko) 2020-04-06
EP2877184B1 (en) 2019-09-04
US20150216877A1 (en) 2015-08-06
CA2880027A1 (en) 2014-01-30
CA2880027C (en) 2021-12-07

Similar Documents

Publication Publication Date Title
US9925201B2 (en) Compositions and treatment for eye diseases and disorders
US12569452B2 (en) Ophthalmic compositions comprising F6H8
EP3362096A1 (en) Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
AU2017357755B2 (en) Formulations for the treatment of ocular surface diseases and related methods
CN111372564B (zh) 用于治疗眼周分泌腺中或眼表上的异常发炎的组合物和方法
US20250041212A1 (en) Compositions and methods for the treatment of anterior blepharitis and posterior blepharitis
EP2424535B1 (en) Methods and compositions for treating dry eye
CN117883380A (zh) 一种用于治疗干眼症的经皮给药的乳剂
TWI632913B (zh) 用於眼部疾病或異常之組合物及其治療方法
HK1210968B (en) Compositions and treatment for eye diseases and disorders
CA3076567C (en) Ophthalmic compositions comprising f6h8
US20140274985A1 (en) Systemic administration of androgen in treating dry eye syndrome
CN105214092B (zh) 重组人白细胞介素-1受体拮抗剂及其组合物及药物用途
EP4259125A1 (en) Apremilast ophthalmic compositions
KR20240130701A (ko) 알라닐-글루타민 및 알라닐-글루타민을 포함하는 안과용 조성물의 새로운 용도
HK40091801A (zh) 含有依匹斯汀或其盐的涂布施予用医药组合物
HK40028751A (en) Ophthalmic compositions comprising f6h8

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180119